480 related articles for article (PubMed ID: 15856429)
1. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
Machens A; Holzhausen HJ; Dralle H
Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
[TBL] [Abstract][Full Text] [Related]
3. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
4. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
6. Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma.
Verburg FA; Mäder U; Luster M; Reiners C
Clin Endocrinol (Oxf); 2009 Aug; 71(2):291-7. PubMed ID: 19067727
[TBL] [Abstract][Full Text] [Related]
7. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
8. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
9. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
10. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma.
Yamashita H; Noguchi S; Murakami N; Kawamoto H; Watanabe S
Cancer; 1997 Dec; 80(12):2268-72. PubMed ID: 9404704
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
12. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
13. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
Hughes CJ; Shaha AR; Shah JP; Loree TR
Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
[TBL] [Abstract][Full Text] [Related]
16. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
[TBL] [Abstract][Full Text] [Related]
17. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
[TBL] [Abstract][Full Text] [Related]
20. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]